Assessment of CEP55, PLK1 and FOXM1 expression in patients with bladder cancer in comparison with healthy individuals-Reference-Cited by-同舟云学术

Assessment of CEP55, PLK1 and FOXM1 expression in patients with bladder cancer in comparison with healthy individuals

Published:2018-09-14 Issue:8 Volume:36 Page:407-414
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Seyedabadi Saman¹,Saidijam Massoud¹^ORCID,Najafi Rezvan¹^ORCID,Mousavi-Bahar Seyed Habibollah²^ORCID,Jafari Mohammad³^ORCID,MohammadGanji Sajjad¹^ORCID,Mahdavinezhad Ali¹^ORCID

Affiliation:

1. Research Center for Molecular Medicine and Genetics, Hamadan University of Medical Sciences, Hamadan, Iran;

2. Urology and Nephrology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran;

3. Department of Pathology, Medical School, Hamadan University of Medical Sciences, Hamadan, Iran

Funder

Hamadan University of Medical Sciences

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2018.1514504

Reference32 articles.

1. New and contemporary markers of prognosis in nonmuscle invasive urothelial cancer

2. Association of Comorbidity, Age, and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma

3. Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis

4. VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway

5. FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of PLK1 and HOXA13 Gene Expression Levels in Urine in the Diagnosis of Non-muscle Invasive Bladder Cancer;Biochemical Genetics;2024-05-07

2. Performance of a PLK1‐based immune risk model for prognosis and treatment response prediction in breast cancer;Cancer Medicine;2023-03-23

3. Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer;Nanomedicine;2023-02

4. Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma;Disease Markers;2022-06-17

5. Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma;Oncology Letters;2022-03-15